*By Bridgette Webb*
Drugmaker Merck announced earlier this month it will slash prices on several drugs by 10 percent or more.
But there is a catch: the price rollback will only affect some of the smaller products in its portfolioーlike Hepatitis C drug, Zepatier, which accounts for about 4 percent of the company's salesーand not top sellers like cancer treatment Keytruda.
"Their scope is relatively limited," said Peter Loftus, a Reporter for the Wall Street Journal, during an interview on Cheddar Monday. "If you think about the total sales that Merck generatesーit's a relatively small percentage."
Merck's announcement was met with praise from the Trump administration. Health and Human Services Secretary Alex Azar claimed the drop in prices was spurred by Trump's latest crackdown on pharmaceutical companies.
Other big pharma names are following suit: Pfizer and Novartis announced they will freeze price increases for the rest of the year, earning them congratulatory tweets from the president.
Despite all of the price freezes and drops, Loftus says that patients may not actually see any real savings.
"I don't think you can say on a widespread basis, and really for the average drug or patient, that prices are coming down, there are still price increases."
For the full segment, [click here.]
(https://cheddar.com/videos/drugmakers-tout-lower-prices)
Melissa Whitely, personal trainer for Life Time Fitness, spoke with Cheddar News about the importance of recovery following a tense workout session. "If we're not going through the proper recovery methods, we can have undue pain, discomfort, tightness in our muscles and all those other things we can avoid," she said.
Dr. Payel Gupta, medical director of allergy, asthma, immunology & ENT for LifeMD.com, joined Cheddar News to discuss some tips on how to cope with allergy season. "With the warmer temperatures, we're seeing that the seasons arrive sooner and actually last longer, and also the elevated CO2 levels actually cause the plants to release more pollen," she said.
A new survey from the National Council for Mental Wellbeing shows that four in five behavioral health workers were concerned that labor shortages in their field “negatively impact society as a whole.”
Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it truly helps patients.
How Accelerated Glacier Melting Is Impacting Rising Sea Levels
A Japanese company's attempt to land a spacecraft on the moon has apparently failed. Flight controllers lost contact Wednesday with the lander after it descended from lunar orbit, aiming for the dusty surface.
A bird strike sparked an engine fire on a plane shortly after takeoff from an Ohio airport on Sunday.
The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
Buick's Global Vice President Talks Development of 'Envista,' Gas-Powered Cars
Peter Krull, a partner and director of sustainable investing at Prime Capital Investment Advisors company Earth Equity Advisors, joined Cheddar News to give some tips on green investments.
